Ueoka Hiroshi

• 肺癌の治療
• Treatment of Lung Cancer

• K Kiura, H Ueoka, Y Segawa, M Tabata, H Kamei, N Takigawa, S Hiraki, Y Watanabe, A Bessho, K Eguchi, et al. Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer. BRITISH JOURNAL OF CANCER. 2003. 89. 5. 795-802
• Y Segawa, H Ueoka, K Kiura, M Tabata, N Takigawa, Y Hiraki, Y Watanabe, T Yonei, T Moritaka, J Hiyama, et al. Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer. LUNG CANCER. 2003. 41. 1. 13-20
• K Fujiwara, K Kiura, H Ueoka, M Tabata, S Hamasaki, M Tanimoto. Dramatic effect of ZD1839 ('Iressa') in a patient with advanced nonsmall-cell lung cancer and poor performance status. LUNG CANCER. 2003. 40. 1. 73-76
• Prognostic significance of mutant p53 protein, p-glycoprotein and glutathione S-transferase-p in patients with unresectable non-small-cell lung cancer. Anticancer Research. 2003. 23, 2837-2844
• Fractionated administration o firinotecan and cisplatin for treatment of extensive disease small-cell lung cancer: A phase II study. Anticancer Research. 2003. 23, 557-560

ｍore...

• - 1975 Okayama University Medical School Faculty of Medicine
• - 1975 Okayama University Faculty of Medicine

• (BLANK)

• 2002 - 日本臨床腫瘍学会 評議員
• 2001 - 日本癌治療学会 評議員
• 2000 - 日本呼吸器学会 評議員
• 1997 - 日本老年医学会 評議員
• 1994 - 日本気管支学会 評議員
1994 - 日本肺癌学会 評議員
1989 - 日本臨床血液学会 評議員

日本臨床腫瘍学会 ,  American Association for Cancer Research ,  American Society of Clinical Oncology ,  International Association for the Study of Lung Cancer ,  日本老年医学会 ,  日本気管支学会 ,  日本肺癌学会 ,  日本臨床血液学会 ,  日本癌治療学会 ,  日本癌学会 ,  日本呼吸器学会 ,  日本血液学会 ,  日本内科学会